Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT05350696
Other study ID # Soh-Med-22-03-10
Secondary ID
Status Not yet recruiting
Phase N/A
First received
Last updated
Start date November 20, 2023
Est. completion date January 1, 2024

Study information

Verified date November 2023
Source Sohag University
Contact Mohamed A Abdelrahman, resident
Phone 01092997390
Email mohamed_aboelhamd_post@med.sohag.edu.eg
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Postoperative pain is often severe in patients undergoing lumbar surgery. Due to postoperative pain, patients are unwilling to get out of bed at an early stage, which affects their recovery. Erector spinae plane block (ESPB) as a new trunk fascia block technique was proposed in 2016. ESPB has aroused the interest of many nerve block experts. The benefits of ESPB are not yet demonstrated. The specific mechanism is still controversial. The erector spinae block is achieved by injecting the local anesthetic solution (with possible adjuvants) between the erector spinae muscles (iliocostalis, longissimus, spinalis/ from lateral to medial) and the transverse process . The technique is performed under ultrasound guidance.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 60
Est. completion date January 1, 2024
Est. primary completion date December 1, 2023
Accepts healthy volunteers No
Gender All
Age group 15 Years to 60 Years
Eligibility Inclusion Criteria: - Lumbar Disc Prolapse. - Fracture Lumbar Vertebrae Exclusion Criteria: 1. Patient refusal. 2. Drug abuse. 3. Patient with significant neurological, psychiatric or neuromuscular disease. 4. Chronic pain on medicine. 5. known allergy to the study medications. 6. Infection at the site of infiltration. 7. Patients with bleeding tendency.

Study Design


Related Conditions & MeSH terms


Intervention

Drug:
Erector Spinae plane block (plain pubivicaine)
The erector spinae block is achieved by injecting the local anesthetic solution (with possible adjuvants) between the erector spinae muscles (iliocostalis, longissimus, spinalis/ from lateral to medial) and the transverse process . The technique is performed under ultrasound guidance.
Intravenous morphine group
patients will receive 0.1 mg /kg of intravenous morphine diluted to 10 ml volume using saline at the end of the operation.

Locations

Country Name City State
Egypt Sohag University Hospital Sohag

Sponsors (1)

Lead Sponsor Collaborator
Sohag University

Country where clinical trial is conducted

Egypt, 

References & Publications (4)

Forero M, Adhikary SD, Lopez H, Tsui C, Chin KJ. The Erector Spinae Plane Block: A Novel Analgesic Technique in Thoracic Neuropathic Pain. Reg Anesth Pain Med. 2016 Sep-Oct;41(5):621-7. doi: 10.1097/AAP.0000000000000451. — View Citation

Hamilton DL, Manickam B. Erector spinae plane block for pain relief in rib fractures. Br J Anaesth. 2017 Mar 1;118(3):474-475. doi: 10.1093/bja/aex013. No abstract available. — View Citation

Melvin JP, Schrot RJ, Chu GM, Chin KJ. Low thoracic erector spinae plane block for perioperative analgesia in lumbosacral spine surgery: a case series. Can J Anaesth. 2018 Sep;65(9):1057-1065. doi: 10.1007/s12630-018-1145-8. Epub 2018 Apr 27. — View Citation

Tseng V, Xu JL. Erector Spinae Plane Block for Postoperative Analgesia in Lumbar Spine Surgery: Is There a Better Option? J Neurosurg Anesthesiol. 2021 Jan;33(1):92. doi: 10.1097/ANA.0000000000000631. No abstract available. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Postoperative analgesia . The study will include 60 adult patients undergoing uncomplicated spine surgery under general anesthesia.
At the end of operation , Patients will be randomly divided using closed enveloped method into two equal groups.
Group 1, (30 patients) will receive bilateral ultrasound guided erector spinae plane block using plain bupivacaine 100 mg diluted to volume using normal saline to achieve 50% concentration ( 50 mg plain pubivicaine in each side ).
Group 2, (30 patients) will receive 0.1 mg /kg of intravenous morphine diluted to 10 ml volume using saline at the end of the operation.
postoperative pain assessment according to visual analogue scale ( VAS ) within 24 hours after the surgery.
0 - 3 mild pain ( better outcome )
4 - 6 moderate pain
7 - 10 severe pain
> 10 unbearable pain ( worst outcome)
24 hours after surgery
Secondary Avoid side effects of using systemic morphine. use of intravenous morphine is mostly followed by undesirable side effects such as postoperative nausea and vomiting,urine retention and constipation.
so the target of this study is to show that if ESPB is more preferrable to IV morphine as regard both : postoperative anagesia and avoidance of side effects of systemic morphine.
patients of morphine group will be asked about having nausea or vomiting after surgery and over 24 hours after the operation.
24 hours after surgery
See also
  Status Clinical Trial Phase
Completed NCT06153511 - Clinical Study With a Robotic Assistant in Patients Requiring a Spinal Transpedicular Fixation N/A
Completed NCT02131571 - Prevalence of Vertebral Fractures in HIV Infected Patients Older Than 50 Years
Completed NCT02781974 - The Effect of Exercise on Physical Function in Older Women With Osteoporosis and a History of Vertebral Fracture N/A